SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Lupin’s arm recalling 39,216 bottles of Lisinopril & Hydrochlorothiazide tablets from US

26 Aug 2019 Evaluate

Lupin’s American subsidiary -- Lupin Pharmaceuticals Inc is recalling 39,216 bottles of Lisinopril and Hydrochlorothiazide tablets USP, 10 mg/12.5 mg, 100 tablet bottle manufactured at its Pithampur facility from the US market. The reason for the recall is presence of foreign substance; product complaints received related to brownish/blackish stains on the tablets and brownish/blackish powder observed inside the bottles. The tablets are used for treatment of hypertension.

Lupin is an innovation led transnational pharmaceutical company developing and delivering a wide range of branded & generic formulations, biotechnology products and APIs globally.

Lupin Share Price

2504.75 47.30 (1.92%)
09-Jul-2026 15:32 View Price Chart
Peers
Company Name CMP
Sun Pharma. Inds. 1938.00
Dr. Reddys Labs. 1270.60
Cipla 1443.00
Zydus Lifesciences 1161.40
Lupin 2504.75
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: